RCM
NXTM

Rotella Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Rotella Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-22,100
Closed -$484K – 315
2015
Q4 		$484K Sell
22,100
-58,000
-72% -$1.08M 0.43% 27
2015
Q3 		$1.26M Buy
+80,100
New +$1.28M 0.41% 97

Other funds holding NXTM

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Rotella Capital Management's NXTM Position: Q1 2016 in Review

Rotella Capital Management sold out of NxStage Medical Inc. (NXTM) in Q1 2016, closing a stake of 22,100 shares — an estimated $484K sold.

Rotella Capital Management first reported a position in NXTM in Q3 2015 and held it in 2 quarters. The position peaked at $1.26M in Q3 2015. 140 funds tracked by Wall St. Rank hold NXTM as of Q1 2016.

  • Rotella Capital Management reported no remaining NxStage Medical Inc. position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 22,100 NxStage Medical Inc. shares in Q1 2016, an estimated $484K.
  • Rotella Capital Management first reported a position in NxStage Medical Inc. in Q3 2015 and held it in 2 quarters.
  • Rotella Capital Management's NxStage Medical Inc. position peaked at $1.26M in Q3 2015.
  • 140 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.